On Friday, Shares of Juno Therapeutics Inc (NASDAQ:JUNO), subtract -2.22% and shut at $29.93 inside the end purchasing and offering session. The last exchanging scope of the stock ranges amongst $29.59 and $30.94. The business’ commercial center capitalization is $2.88 Billion with the aggregate fabulous loads of 105.87 million. Juno Therapeutics, Inc. (JUNO), a biopharmaceutical company focused on re-engaging the body’s immune system to revolutionize the treatment of cancer, recently stated financial results and business highlights for the third quarter 2016.
“JCAR017, a key product candidate of our CD19 platform, has shown encouraging preliminary efficacy and safety results in NHL and pediatric ALL. At the forthcoming American Society of Hematology meeting, additional data from our Phase I trial for JCAR017 in NHL patients will be presented,” said Hans Bishop, Juno’s President and Chief Executive Officer. “Progress with CAR T therapy continues as we strive to bring these innovative product candidates to patients battling cancer. We look forward to the forthcoming presentations at ASH, counting 11 total presentations from a number of ongoing and accomplished studies.”
Shares of Kulicke and Soffa Industries Inc. (NASDAQ:KLIC), subtract -3.46% and shut at $14.80 inside the last exchanging session. The rest of the purchasing and offering scope of the stock levels among $14.48 and $15.37. The association’s commercial center capitalization is $1.01 Billion with the general uncommon loads of 70.88 million. Kulicke and Soffa Industries, Inc. (KLIC) (“Kulicke & Soffa”, “K&S” or the “Company”) recently declared results for its fourth quarter and fiscal year ended October 1, 2016.
Dr. Fusen Chen, Kulicke & Soffa’s President and Chief Executive Officer, stated, “For the September quarter, we have exceeded our revenue guidance and practiced improved demand over the same period in the prior fiscal year. This better-than-expected performance was mostly because of the strengthening of the memory segment and new traction within the automotive segment.”